老年黑人和西班牙裔心衰患者中的转甲状腺素心脏淀粉样变
这项前瞻性多中心横断面研究纳入646例自认黑人或加勒比西班牙裔的60岁以上心衰患者,用核素显像诊断ATTR-CA并基因分型。总体患病率为6.66%,其中55.8%为野生型,44.2%为V142I突变型;黑人患病率高于西班牙裔,75岁以上黑人男性患病率达17.17%。
要点
- 老年黑人及加勒比西班牙裔心衰患者中ATTR-CA总体患病率为6.66%。
- V142I携带者中心衰患者约半数合并ATTR-CA,需警惕该突变。
- 75岁以上黑人男性ATTR-CA患病率最高,达17.17%。
核心结论
- 在老年黑人心衰患者中,ATTR-CA是重要病因,尤其是75岁以上男性。
- V142I携带者合并心衰时约半数存在ATTR-CA,而全部ATTR-CA病例中55.8%为正常TTR基因型。
研究设计与样本
- 前瞻性、多中心、横断面研究,纳入美国多个大城市中自认黑人或加勒比西班牙裔、年龄大于60岁的心衰患者646例。
- 入组时间为2019年5月至2024年6月,数据分析时间为2024年6月至2025年5月。
- ATTR-CA通过核素显像诊断,血液检测排除轻链淀粉样变,基因分型确定TTR基因变异。
主要发现
- 总体ATTR-CA患病率为6.66%(95%CI 4.73%-8.58%),其中24例(55.8%)为ATTRwt-CA,19例(44.2%)为V142I所致ATTRv-CA。
- V142I等位基因总体患病率为5.6%,携带者中19例(52.8%)有ATTRv-CA。
临床怎么用
- 对老年黑人及加勒比西班牙裔心衰患者,尤其75岁以上男性,应提高对ATTR-CA的筛查意识。
- 对携带V142I变异的心衰患者,需评估合并ATTR-CA的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Transthyretin cardiac amyloidosis (ATTR-CA) is an underdiagnosed but treatable cause of heart failure (HF) in older individuals that occurs in the context of normal wild-type (ATTRwt-CA) or an abnormal inherited (ATTRv-CA) TTR gene variant. While the most common inherited TTR variant, V142I, occurs in 3% to 4% of self-identified Black Americans and is associated with excess morbidity and mortality, the prevalence of ATTR-CA in this at-risk population is unknown. OBJECTIVE: To define the prevalence of ATTR-CA and proportions attributable to ATTRwt-CA or ATTRv-CA among older Black and Caribbean Hispanic individuals with HF. DESIGN, SETTING, AND PARTICIPANTS: This prospective, multicenter, cross-sectional study was conducted in several major US cities (Boston, Massachusetts; New York, New York; and New Haven, Connecticut) among individuals who self-identified as Black or Caribbean Hispanic older than 60 years with HF. Participants were enrolled between May 2019 and June 2024, and data analysis was conducted from June 2024 to May 2025. MAIN OUTCOMES AND MEASURES: ATTR-CA was determined by radionuclide imaging, with blood testing to exclude light-chain amyloidosis and genotyping to determine TTR gene variant. Echocardiographic, biochemical, physical performance, and quality-of-life data were collected. RESULTS: Among 646 participants, median (IQR) participant age was 73 (66-80) years, 329 (50.6%) were women, 550 (85.1%) identified as Black, and 186 (28.8%) identified as Caribbean Hispanic. Median (IQR) left ventricular wall thickness was 13 (12-14) mm, and median (IQR) left ventricular ejection fraction was 61% (55%-66%). Overall prevalence of ATTR-CA was 6.66% (95% CI, 4.73%-8.58%), of whom 24 (55.8%) had ATTRwt-CA and 19 (44.2%) had ATTRv-CA owing to V142I. Overall prevalence of V142I allele was 5.6%, and of those, 19 (52.8%) had ATTRv-CA. Prevalence of ATTR-CA was 8.15% (95% CI, 5.15%-11.15%) in men and 5.20% (95% CI, 2.79%-7.61%) in women (P = .13). Prevalence of ATTR-CA was 7.82% (95% CI, 5.57%-10.06%) in Black participants and 2.15% (95% CI, 0.07%-4.24%) in Hispanic participants (P = .004). Among Black participants aged 75 years or younger, ATTR-CA was observed in 3.42% of participants (95% CI, 1.43%-5.40%) compared to 14.04% (95% CI, 9.53%-18.54%) of those older than 75 years (P < .001). Among Black male participants older than 75 years, prevalence of ATTR-CA was 17.17% (95% CI, 9.74%-24.60%). CONCLUSIONS AND RELEVANCE: In this cross-sectional study, ATTR-CA was an important cause of HF in older Black individuals with HF, particularly in men older than 75 years. Approximately half of V142I carriers with HF had ATTR-CA, while 55.8% of all ATTR-CA cases had normal TTR genotype. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03812172.
引用
- Ruberg, Teruya, Helmke, et al. Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. 2025. PMID: 40928765. doi:10.1001/jamacardio.2025.2948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。